Epoch scales polymer biorecycling with Domo factory

Epoch purchased a commercial-scale polymer biorecycling factory in Spain from Domo Chemicals for €4m after the Spanish unit entered insolvency, aiming to scale enzymatic recycling of nylon 6,6. The site has 52,000t/year capacity and adds 60 jobs. Epoch says it can supply closed-loop recycled nylon ahead of EU rules, and earlier raised $12m from lululemon and others.

Original reporting
Published Aug 3, 2026, 10:05 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 10:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMergers & acquisitions
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$DOMO
Relevance
7/10
alphai data visualization · based on just-style.com
Decision brief

The 30-second read

Med
01

Why it matters

Owning the production site at 52,000t/year supports Epoch’s pitch of closed-loop recycled nylon 6,6 that is indistinguishable from fossil-derived material, aiming to meet brand targets ahead of EU recycled-content tightening in 2030.

02

Market read

Traders can treat this as a commercialization milestone: a priced acquisition plus stated capacity and a customer-validation plan, which may shift expectations for recycled nylon supply timelines.

03

What to watch

The article does not quantify capex/operating costs, expected utilization rate, or signed offtake volumes, which are key to assessing earnings impact.

Relevance 7/10Novelty 7/10Timing: today, fresh deal details on acquisition price and 52,000t/year capacity

Background

Epoch acquired a factory previously run by Domo Chemicals after Domo’s Spanish business entered insolvency, positioning Epoch as an owner-operator of commercial-scale enzymatic recycling.

Market effects

Could strengthen competitive positioning for enzymatic recycling and closed-loop nylon 6,6 supply as brands seek reliable feedstock ahead of EU recycled-content rules.

European materials and recycling supply chain focus, centered on the Blanes site and Spanish insolvency context.

If validated at scale, may influence global recycled nylon availability and pricing dynamics for apparel and industrial customers.

Counterpoint

Scale claims may not translate into near-term volumes or margins if enzyme yield, feedstock availability, or customer qualification timelines lag.

Key entities

  • Epoch

    Enzymatic recycler expanding nylon 6,6 recycled polymer production via a €4m factory acquisition.

  • Domo Chemicals

    Former operator of the Blanes site; its Spanish business entered insolvency before Epoch purchased the factory.

  • lululemon

    Investor in Epoch’s earlier $12m funding round to accelerate commercialization.

  • KOMPAS VC

    Co-investor in Epoch’s $12m investment round.

  • Extantia

    Co-investor in Epoch’s $12m investment round.

Related articles

$DOMOMedAI 8/10

Utah tech leader who coined 'Silicon Slopes' selling his company for $400M

Domo, an analytics firm, said it agreed to be acquired by Progress Software for $400 million. Progress will take substantially all of Domo’s assets and employees and assume some liabilities, excluding carried net operating losses. After closing, Domo will change its name and ticker but remain publicly traded. The article also recounts Domo founder Josh James’ “Silicon Slopes” legacy and Domo’s prior valuation and financials.

$DOMOMedAI 9/10

Progress Software Agrees to Acquire Domo's AI and Data Platform Business for $400 Million in Cash, Transaction Structured as Asset Purchase

According to a deal announcement, Progress Software will acquire Domo’s AI and data platform business for $400 million in cash, structured as an asset purchase. The agreement covers Domo’s AI and data platform operations and is intended to expand Progress’s offerings. Investors may track Progress’s acquisition impact on growth and cash use.

$HUTMedAI 8/10

Vita Coco, Domo rallies, Mobileye falls premarket in earnings deluge By Investing.com

U.S. stock index futures fell as investors weighed technology earnings and Middle East tensions that pushed oil above $98. Vita Coco rose after Q2 net sales of $216M and adjusted EBITDA of $67M. Hut 8 gained on Morgan Stanley’s Overweight and $263 target. Mobileye fell on CEO Amnon Shashua stepping down. Domo jumped 21% after Progress Software to buy assets for $400M cash.

$PRGSMedAI 8/10

Progress Software Bets on AI With $400 Million Deal for Domo’s Data Platform

Progress Software (NASDAQ:PRGS) said it will buy Domo’s cloud-native AI and data platform in a $400 million deal, aiming to combine Domo’s ingestion and RAG capabilities with Progress’ structured and unstructured data management. Progress noted Domo has 2,400 customers and over 85% consumption-based ARR. Progress expects about 2% ARR growth this year.

$SRLZFMed

Salazar Resources Limited: Salazar Resources Reports El Domo After-Tax NPV (8% Discount Rate) of US$573 Million, Representing a 121% Increase Compared to the October 2021 Feasibility Study

Salazar Resources Limited (TSXV: SRL, OTCQB: SRLZF) reported an updated NI 43-101 Technical Report for its Curipamba-El Domo polymetallic project in Ecuador, prepared by SRK Consulting for operator Silvercorp Metals (75%). Salazar’s 25% carried interest. After-tax NPV(8%) is US$573m, up 121% vs the 2021 feasibility study. Construction is fully funded, first production expected mid-2027.

$FOXMed

Deal Dispatch: Yum! Brands Sells Pizza Hut, Fox Corp. Buys Roku For $22 Billion, Salesforce Acquires Fin

The article says Domo is in advanced talks over a potential transaction and recently signed a forbearance agreement after breaching a minimum annualized recurring revenue covenant. It also notes Fox’s planned $22B Roku purchase (closing H1 2027) and Nuvei’s nearly $2.75B all-cash bid for Payoneer (mid-2027). It adds Simulations Plus will be acquired by Altaris for $18.50/share and lists several Chapter 11 filings.